G. Velikova
About
G. Velikova is a scholar working on Oncology, Economics and Econometrics and Public Health, Environmental and Occupational Health.
According to data from OpenAlex, G. Velikova has authored 23 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Economics and Econometrics and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in G. Velikova's work include Economic and Financial Impacts of Cancer (5 papers), Cancer survivorship and care (4 papers) and Palliative Care and End-of-Life Issues (4 papers). G. Velikova is often cited by papers focused on Economic and Financial Impacts of Cancer (5 papers), Cancer survivorship and care (4 papers) and Palliative Care and End-of-Life Issues (4 papers). G. Velikova collaborates with scholars based in United Kingdom, Portugal and Netherlands. G. Velikova's co-authors include L. HAROLD DEWOLF, Michael Koller, Andrew Bottomley, Neil Scott, Colin A. Johnson, Penny Wright, Peter J. Selby, A. Cull, Mike Crawford and Timothy Perren and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and European Journal of Cancer.
In The Last Decade
G. Velikova
19 papers receiving 401 citations
Peers
G. Velikova
Dympna Waldron Ireland
Briony Williams Canada
Carmen Beato Spain
Helge Danker Germany
Gareth Davies United Kingdom
Jayita Deodhar India
Estela Cristina Carneseca Brazil
Veronica Nanton United Kingdom
Katherine Milette Canada
Carole Mayer Canada
Citations per year, relative to G. Velikova G. Velikova (= 1×)
peers
Dympna Waldron
Countries citing papers authored by G. Velikova
Since
Specialization
Citations
This map shows the geographic impact of G. Velikova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Velikova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Velikova more than expected).
Fields of papers citing papers by G. Velikova
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by G. Velikova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Velikova. The network helps show where G. Velikova may publish in the future.
Co-authorship network of co-authors of G. Velikova
This figure shows the co-authorship network connecting the top 25 collaborators of G. Velikova. A scholar is included among the top collaborators of G. Velikova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Velikova. G. Velikova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ligt, Kelly M. de, Linetta B. Koppert, Belle H. de Rooij, et al.. (2024). Seizing the moment: The time for harnessing electronic patient-reported outcome measures for enhanced and sustainable metastatic breast cancer care is now. The Breast. 74. 103676–103676.
2.
Clegg, Andrew, et al.. (2023). Introducing the Frailty-inforRmed cAncer ManagemEnt (FRAME) intervention development study. Journal of Geriatric Oncology. 14(8). S36–S37.
3.
Ligt, Kelly M. de, Belle H. de Rooij, Elham Hedayati, et al.. (2022). International development of a patient-centered core outcome set for assessing health-related quality of life in metastatic breast cancer patients. Zenodo (CERN European Organization for Nuclear Research).
4.
Swinson, Daniel, et al.. (2021). Frailty and treatment outcome in advanced gastro-oesophageal cancer: an exploratory analysis of the GO2 trial. Journal of Geriatric Oncology. 12(8). S35–S35.
5.
Piccinin, Claire, et al.. (2020). B202.7 Use of the Common Terminology Criteria for Adverse Events (CTCAE) framework to summarize symptomatic toxicities in the European Organisation for Research and Treatment of Cancer (EORTC) Item Library. White Rose Research Online (University of Leeds, The University of Sheffield, University of York).
6.
Holch, Patricia, Shohreh Dickinson, S.E. Davidson, et al.. (2017). Development of online patient advice for the self-management of low-level radiotherapy and chemotherapy related toxicities (eRAPID): involvement of patients and staff.. Psycho-Oncology.
7.
Holch, Patricia, Andrew Gibson, Melissa Galea Holmes, et al.. (2016). Usability testing of an online symptom report and management system in radical prostate radiotherapy (RT) patients: preliminary findings of the eRAPID RT programme. Psycho-Oncology.
8.
Holch, Patricia, Michelle M. Holmes, Zoe Rogers, et al.. (2016). Seeking consensus from staff and patients on appropriate patient-reported outcome (PRO) items for radical prostate patients in the eRAPID (Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice) project: a Delphi study.
9.
Rogers, Zoe, Patricia Holch, Michelle M. Holmes, et al.. (2016). Healthcare professional (HCP) attitudes to the implementation of eRAPID (Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice) during and after pelvic radiotherapy: a qualitative interview study.
10.
Holmes, Michelle M., Patricia Holch, Zoe Rogers, et al.. (2016). Patient and relatives attitudes to the implementation of eRAPID (Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice) during and after pelvic radiotherapy: a qualitative interview study.
11.
Cameron, David, Judith M. Bliss, Peter Barrett‐Lee, et al.. (2015). 1231 Cost-effectiveness analysis of the use of pegfilgrastim to enable accelerated adjuvant chemotherapy in the TACT2 trial (CRUK/05/019). European Journal of Cancer. 51. S183–S184.
12.
Holch, Patricia, S.E. Davidson, Jacqueline A Routledge, et al.. (2015). OC-0416: eRAPID: Electronic self-report and management of adverse-events for radical prostate radiotherapy (RT) patients. Radiotherapy and Oncology. 115. S202–S202.
13.
Bliss, Judith M., Peter Canney, G. Velikova, et al.. (2010). Abstract P5-10-07: TACT2 Randomised Adjuvant Trial in Early Breast Cancer (EBC): Tolerability and Toxicity of Standard 3 Weekly Epirubicin (E) Versus Accelerated Epirubicin (aE) Followed by Capecitabine (X) or CMF in 129 UK Hospitals (CRUK/05/019). Cancer Research. 70(24_Supplement). P5–10.
14.
Kunkler, I., Peter Canney, Joanna Dunlop, et al.. (2009). MRC SUPREMO (SELECTED USE OF POSTOPERATIVE RADIOTHERAPY AFTER MASTECTOMY) (BIG 2-04/EORTC 22051)- A PHASE III MULTICENTRE INTERNATIONAL RANDOMISED TRIAL ASSESSING THE ROLE OF ADJUVANT CHEST WALL IRRADIATION IN 'INTERMEDIATE RISK' OPERABLE BREAST CANCER FOLLOWING MASTECTOMY AND AXILLARY SURGERY. 20. 28–28.
15.
Claassens, L., Jan P. van Meerbeeck, Corneel Coens, et al.. (2009). Health-related quality of life (HRQOL) in non-small cell lung cancer (NSCLC): An update of a systematic review on methodological issues in randomized controlled trials (RCTs). Journal of Clinical Oncology. 27(15_suppl). 9604–9604.
16.
DEWOLF, L. HAROLD, Michael Koller, G. Velikova, et al.. (2009). EORTC Quality of Life Group translation procedure.
17.
Hodges, L., Annet Kleiboer, Michael Sharpe, et al.. (2009). What is a psychological intervention? A meta-review of narrative reviews, systematic reviews and meta-analyses in patients with cancer. Research Portal (King's College London). 18(3). 319–319.
18.
Velikova, G., et al.. (2008). Randomized trial of quality-of-life measurement in oncology practice: Do oncologists need to know?. Journal of Clinical Oncology. 26(15_suppl). 9586–9586.
19.
Kunkler, I., Peter Canney, Geertjan van Tienhoven, et al.. (2007). P88 MRC/EORTC (BIG 2–04) SUPREMO – a phase III trial assessing the role of chest wall irradiation in ‘intermediate-risk’ breast cancer. The Breast. 16. S37–S37.
20.
Velikova, G., et al.. (1999). Self-reported quality of life (QL) of individual cancer patients — Concordance of results with clinical course and medical records. European Journal of Cancer. 35. S277–S277.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Dympna Waldron Breakdown of academic impact, for papers by Briony Williams Breakdown of academic impact, for papers by Carmen Beato Breakdown of academic impact, for papers by Helge Danker Breakdown of academic impact, for papers by Gareth Davies Breakdown of academic impact, for papers by Jayita Deodhar Breakdown of academic impact, for papers by Estela Cristina Carneseca Breakdown of academic impact, for papers by Veronica Nanton Breakdown of academic impact, for papers by Katherine Milette Breakdown of academic impact, for papers by Carole Mayer